Skip to main content
HR 4080 117th Congress House International Affairs Administrative remedies Appropriations Asia Cardiovascular and respiratory health China Congressional oversight Economic performance and conditions Emergency medical services and trauma care Government ethics and transparency, public corruption Government liability Government trust funds Health programs administration and funding Infectious and parasitic diseases International organizations and cooperation Political parties and affiliation State and local finance Tariffs World health

China COVID–19 Restitution Act

Introduced: June 23, 2021 See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
Jun 23, 2021
Referred to the Subcommittee on Trade.
Jun 23, 2021
Referred to the Committee on Ways and Means, and in addition to the Committees on the Judiciary, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 23, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

China COVID-19 Restitution Act

This bill requires the President to impose duties on goods and components manufactured in China and to use the collected funds to provide compensation and reimbursement for losses related to COVID-19.

From this bill's enactment until December 31, 2021, the President must impose a 10% ad valorem duty on any good manufactured in China and any component manufactured in China and incorporated in a good imported from any country. This duty shall increase by an additional 10% each calendar year after 2021.

The amounts from this duty shall go into a trust fund, which shall also include any amounts provided by China's government to provide compensation and reimbursement related to COVID-19.

Using the amounts in the trust fund, the Department of Justice shall establish and administer a program to provide compensation and reimbursement for economic and financial losses related to COVID-19, including for assistance made available by the federal government.

What's happening now November 1, 2022

Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4080: China COVID–19 Restitution Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-4080/
MLA
"H.R. 4080: China COVID–19 Restitution Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-4080/.
Bluebook (legal)
H.R. 4080, 117th Cong. (2026), https://openamerica.io/bill/117-HR-4080/.
Markdown link
[H.R. 4080: China COVID–19 Restitution Act](https://openamerica.io/bill/117-HR-4080/)
Report a problem